Burden of Respiratory Syncytial Virus Infection in South African Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Pregnant and Postpartum Women: A Longitudinal Cohort Study-Reference-Cited by-同舟云学术

Burden of Respiratory Syncytial Virus Infection in South African Human Immunodeficiency Virus (HIV)-Infected and HIV-Uninfected Pregnant and Postpartum Women: A Longitudinal Cohort Study

Published:2017-12-15 Issue:11 Volume:66 Page:1658-1665
ISSN:1058-4838
Container-title:Clinical Infectious Diseases
language:en
Short-container-title:

Author:

Madhi Shabir A¹²,Cutland Clare L¹²,Downs Sarah¹²,Jones Stephanie¹²,van Niekerk Nadia¹²,Simoes Eric A F¹³⁴,Nunes Marta C¹²

Affiliation:

1. Respiratory and Meningeal Pathogens Research Unit, Medical Research Council

2. Department of Science and Technology, National Research Foundation, Vaccine Preventable Diseases, University of the Witwatersrand, Johannesburg, South Africa

3. Department of Pediatrics, University of Colorado School of Medicine

4. Center for Global Health, Colorado School of Public Health, Aurora

Funder

Bill and Melinda Gates Foundation

National Research Foundation

Medical Research Council

Publisher

Oxford University Press (OUP)

Subject

Infectious Diseases,Microbiology (medical)

Link

http://academic.oup.com/cid/article-pdf/66/11/1658/25084204/cix1088.pdf

Reference16 articles.

1. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study;Shi;Lancet,2017

2. Seasonal variation of maternally derived respiratory syncytial virus antibodies and association with infant hospitalizations for respiratory syncytial virus;Stensballe;J Pediatr,2009

3. Prevalence of respiratory syncytial virus IgG antibodies in infants living in a rural area of Mozambique;Roca;J Med Virol,2002

4. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants;Pediatrics,1998

5. A randomized, blinded, controlled, dose-ranging study of a respiratory syncytial virus recombinant fusion (F) nanoparticle vaccine in healthy women of childbearing age;Glenn;J Infect Dis,2016

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Occurrence of Central Nervous System Complications of Respiratory Syncytial Virus Infections: A Systematic Review with Meta-Analysis;Epidemiologia;2024-07-19

2. Efficacy of Respiratory Syncytial Virus Vaccination to Prevent Lower Respiratory Tract Illness in Older Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials;Vaccines;2024-05-05

3. Respiratory Syncytial Virus Infections in Recipients of Bone Marrow Transplants: A Systematic Review and Meta-Analysis;Infectious Disease Reports;2024-03-29

4. Pregnant patients with respiratory syncytial virus infection: assessment of characteristics and maternal morbidity at delivery;AJOG Global Reports;2024-02

5. Characteristics and Outcomes of Pregnant Women Hospitalized With Laboratory-Confirmed Respiratory Syncytial Virus Before and During the COVID-19 Pandemic;Open Forum Infectious Diseases;2024-01-31